img

Global Recombinant Human Parathyroid Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Recombinant Human Parathyroid Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
Recombinant Human Parathyroid Hormone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Human Parathyroid Hormone market is projected to reach US$ 228.5 million in 2029, increasing from US$ 144 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Postmenopausal Women with Osteoporosis and Hypocalcemia in Patients with Hypoparathyroidism are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Human Parathyroid Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


NPS Pharma(Shire)
Takeda
Shandong Buchang Pharmaceuticals
Ascendis Pharma
Beijing SL Pharmaceutical
Segment by Type
25 mcg/dose
50 mcg/dose
75 mcg/dose
100 mcg/dose

Segment by Application


Postmenopausal Women with Osteoporosis
Hypocalcemia in Patients with Hypoparathyroidism

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Human Parathyroid Hormone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Human Parathyroid Hormone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Human Parathyroid Hormone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Human Parathyroid Hormone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Human Parathyroid Hormone introduction, etc. Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Recombinant Human Parathyroid Hormone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Recombinant Human Parathyroid Hormone Market Overview
1.1 Recombinant Human Parathyroid Hormone Product Overview
1.2 Recombinant Human Parathyroid Hormone Market Segment by Type
1.2.1 25 mcg/dose
1.2.2 50 mcg/dose
1.2.3 75 mcg/dose
1.2.4 100 mcg/dose
1.3 Global Recombinant Human Parathyroid Hormone Market Size by Type
1.3.1 Global Recombinant Human Parathyroid Hormone Market Size Overview by Type (2018-2029)
1.3.2 Global Recombinant Human Parathyroid Hormone Historic Market Size Review by Type (2018-2024)
1.3.3 Global Recombinant Human Parathyroid Hormone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2018-2024)
1.4.2 Europe Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2018-2024)
2 Global Recombinant Human Parathyroid Hormone Market Competition by Company
2.1 Global Top Players by Recombinant Human Parathyroid Hormone Sales (2018-2024)
2.2 Global Top Players by Recombinant Human Parathyroid Hormone Revenue (2018-2024)
2.3 Global Top Players by Recombinant Human Parathyroid Hormone Price (2018-2024)
2.4 Global Top Manufacturers Recombinant Human Parathyroid Hormone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Human Parathyroid Hormone Market Competitive Situation and Trends
2.5.1 Recombinant Human Parathyroid Hormone Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Parathyroid Hormone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2022)
2.7 Date of Key Manufacturers Enter into Recombinant Human Parathyroid Hormone Market
2.8 Key Manufacturers Recombinant Human Parathyroid Hormone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Recombinant Human Parathyroid Hormone Status and Outlook by Region
3.1 Global Recombinant Human Parathyroid Hormone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Recombinant Human Parathyroid Hormone Historic Market Size by Region
3.2.1 Global Recombinant Human Parathyroid Hormone Sales in Volume by Region (2018-2024)
3.2.2 Global Recombinant Human Parathyroid Hormone Sales in Value by Region (2018-2024)
3.2.3 Global Recombinant Human Parathyroid Hormone Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Recombinant Human Parathyroid Hormone Forecasted Market Size by Region
3.3.1 Global Recombinant Human Parathyroid Hormone Sales in Volume by Region (2024-2029)
3.3.2 Global Recombinant Human Parathyroid Hormone Sales in Value by Region (2024-2029)
3.3.3 Global Recombinant Human Parathyroid Hormone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Recombinant Human Parathyroid Hormone by Application
4.1 Recombinant Human Parathyroid Hormone Market Segment by Application
4.1.1 Postmenopausal Women with Osteoporosis
4.1.2 Hypocalcemia in Patients with Hypoparathyroidism
4.2 Global Recombinant Human Parathyroid Hormone Market Size by Application
4.2.1 Global Recombinant Human Parathyroid Hormone Market Size Overview by Application (2018-2029)
4.2.2 Global Recombinant Human Parathyroid Hormone Historic Market Size Review by Application (2018-2024)
4.2.3 Global Recombinant Human Parathyroid Hormone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2018-2024)
4.3.2 Europe Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2018-2024)
5 North America Recombinant Human Parathyroid Hormone by Country
5.1 North America Recombinant Human Parathyroid Hormone Historic Market Size by Country
5.1.1 North America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Recombinant Human Parathyroid Hormone Sales in Volume by Country (2018-2024)
5.1.3 North America Recombinant Human Parathyroid Hormone Sales in Value by Country (2018-2024)
5.2 North America Recombinant Human Parathyroid Hormone Forecasted Market Size by Country
5.2.1 North America Recombinant Human Parathyroid Hormone Sales in Volume by Country (2024-2029)
5.2.2 North America Recombinant Human Parathyroid Hormone Sales in Value by Country (2024-2029)
6 Europe Recombinant Human Parathyroid Hormone by Country
6.1 Europe Recombinant Human Parathyroid Hormone Historic Market Size by Country
6.1.1 Europe Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Recombinant Human Parathyroid Hormone Sales in Volume by Country (2018-2024)
6.1.3 Europe Recombinant Human Parathyroid Hormone Sales in Value by Country (2018-2024)
6.2 Europe Recombinant Human Parathyroid Hormone Forecasted Market Size by Country
6.2.1 Europe Recombinant Human Parathyroid Hormone Sales in Volume by Country (2024-2029)
6.2.2 Europe Recombinant Human Parathyroid Hormone Sales in Value by Country (2024-2029)
7 Asia-Pacific Recombinant Human Parathyroid Hormone by Region
7.1 Asia-Pacific Recombinant Human Parathyroid Hormone Historic Market Size by Region
7.1.1 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Recombinant Human Parathyroid Hormone Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Recombinant Human Parathyroid Hormone Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Recombinant Human Parathyroid Hormone Forecasted Market Size by Region
7.2.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Recombinant Human Parathyroid Hormone Sales in Value by Region (2024-2029)
8 Latin America Recombinant Human Parathyroid Hormone by Country
8.1 Latin America Recombinant Human Parathyroid Hormone Historic Market Size by Country
8.1.1 Latin America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Recombinant Human Parathyroid Hormone Sales in Volume by Country (2018-2024)
8.1.3 Latin America Recombinant Human Parathyroid Hormone Sales in Value by Country (2018-2024)
8.2 Latin America Recombinant Human Parathyroid Hormone Forecasted Market Size by Country
8.2.1 Latin America Recombinant Human Parathyroid Hormone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Recombinant Human Parathyroid Hormone Sales in Value by Country (2024-2029)
9 Middle East and Africa Recombinant Human Parathyroid Hormone by Country
9.1 Middle East and Africa Recombinant Human Parathyroid Hormone Historic Market Size by Country
9.1.1 Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Recombinant Human Parathyroid Hormone Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Recombinant Human Parathyroid Hormone Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Recombinant Human Parathyroid Hormone Forecasted Market Size by Country
9.2.1 Middle East and Africa Recombinant Human Parathyroid Hormone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Recombinant Human Parathyroid Hormone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 NPS Pharma(Shire)
10.1.1 NPS Pharma(Shire) Company Information
10.1.2 NPS Pharma(Shire) Introduction and Business Overview
10.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2018-2024)
10.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Products Offered
10.1.5 NPS Pharma(Shire) Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Takeda Recombinant Human Parathyroid Hormone Products Offered
10.2.5 Takeda Recent Development
10.3 Shandong Buchang Pharmaceuticals
10.3.1 Shandong Buchang Pharmaceuticals Company Information
10.3.2 Shandong Buchang Pharmaceuticals Introduction and Business Overview
10.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Products Offered
10.3.5 Shandong Buchang Pharmaceuticals Recent Development
10.4 Ascendis Pharma
10.4.1 Ascendis Pharma Company Information
10.4.2 Ascendis Pharma Introduction and Business Overview
10.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Products Offered
10.4.5 Ascendis Pharma Recent Development
10.5 Beijing SL Pharmaceutical
10.5.1 Beijing SL Pharmaceutical Company Information
10.5.2 Beijing SL Pharmaceutical Introduction and Business Overview
10.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Products Offered
10.5.5 Beijing SL Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Recombinant Human Parathyroid Hormone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Recombinant Human Parathyroid Hormone Industrial Chain Analysis
11.4 Recombinant Human Parathyroid Hormone Market Dynamics
11.4.1 Recombinant Human Parathyroid Hormone Industry Trends
11.4.2 Recombinant Human Parathyroid Hormone Market Drivers
11.4.3 Recombinant Human Parathyroid Hormone Market Challenges
11.4.4 Recombinant Human Parathyroid Hormone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Recombinant Human Parathyroid Hormone Distributors
12.3 Recombinant Human Parathyroid Hormone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 25 mcg/dose
Table 2. Major Company of 50 mcg/dose
Table 3. Major Company of 75 mcg/dose
Table 4. Major Company of 100 mcg/dose
Table 5. Global Recombinant Human Parathyroid Hormone Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (K Units)
Table 7. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (US& Million)
Table 9. Global Recombinant Human Parathyroid Hormone Market Share in Value by Type (2018-2024)
Table 10. Global Recombinant Human Parathyroid Hormone Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Recombinant Human Parathyroid Hormone Sales by Type (2024-2029) & (K Units)
Table 12. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Recombinant Human Parathyroid Hormone Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type (2024-2029)
Table 15. Global Recombinant Human Parathyroid Hormone Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (K Units)
Table 17. North America Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Recombinant Human Parathyroid Hormone Sales (K Units) by Type (2018-2024)
Table 19. Europe Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Recombinant Human Parathyroid Hormone Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Recombinant Human Parathyroid Hormone Sales (K Units) by Type (2018-2024)
Table 23. Latin America Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Recombinant Human Parathyroid Hormone Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Recombinant Human Parathyroid Hormone Sales by Company (2018-2024) & (K Units)
Table 27. Global Recombinant Human Parathyroid Hormone Sales Share by Company (2018-2024)
Table 28. Global Recombinant Human Parathyroid Hormone Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Recombinant Human Parathyroid Hormone Revenue Share by Company (2018-2024)
Table 30. Global Market Recombinant Human Parathyroid Hormone Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Recombinant Human Parathyroid Hormone Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Recombinant Human Parathyroid Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2022)
Table 34. Date of Key Manufacturers Enter into Recombinant Human Parathyroid Hormone Market
Table 35. Key Manufacturers Recombinant Human Parathyroid Hormone Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Recombinant Human Parathyroid Hormone Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Recombinant Human Parathyroid Hormone Sales by Region (2018-2024) & (K Units)
Table 39. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Recombinant Human Parathyroid Hormone Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Region (2018-2024)
Table 42. Global Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Recombinant Human Parathyroid Hormone Sales by Region (2024-2029) & (K Units)
Table 44. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Recombinant Human Parathyroid Hormone Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Region (2024-2029)
Table 47. Global Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Recombinant Human Parathyroid Hormone Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (K Units)
Table 50. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application (2018-2024)
Table 53. Global Recombinant Human Parathyroid Hormone Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Recombinant Human Parathyroid Hormone Sales by Application (2024-2029) & (K Units)
Table 55. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Recombinant Human Parathyroid Hormone Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application (2024-2029)
Table 58. Global Recombinant Human Parathyroid Hormone Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) (K Units)
Table 60. North America Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) (K Units)
Table 62. Europe Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) (K Units)
Table 66. Latin America Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (K Units)
Table 70. North America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2018-2024)
Table 73. North America Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (K Units)
Table 74. North America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (K Units)
Table 78. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (K Units)
Table 82. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Value by Country (2024-2029)
Table 109. NPS Pharma(Shire) Company Information
Table 110. NPS Pharma(Shire) Introduction and Business Overview
Table 111. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product
Table 113. NPS Pharma(Shire) Recent Development
Table 114. Takeda Company Information
Table 115. Takeda Introduction and Business Overview
Table 116. Takeda Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Takeda Recombinant Human Parathyroid Hormone Product
Table 118. Takeda Recent Development
Table 119. Shandong Buchang Pharmaceuticals Company Information
Table 120. Shandong Buchang Pharmaceuticals Introduction and Business Overview
Table 121. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product
Table 123. Shandong Buchang Pharmaceuticals Recent Development
Table 124. Ascendis Pharma Company Information
Table 125. Ascendis Pharma Introduction and Business Overview
Table 126. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Ascendis Pharma Recombinant Human Parathyroid Hormone Product
Table 128. Ascendis Pharma Recent Development
Table 129. Beijing SL Pharmaceutical Company Information
Table 130. Beijing SL Pharmaceutical Introduction and Business Overview
Table 131. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product
Table 133. Beijing SL Pharmaceutical Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Recombinant Human Parathyroid Hormone Market Trends
Table 137. Recombinant Human Parathyroid Hormone Market Drivers
Table 138. Recombinant Human Parathyroid Hormone Market Challenges
Table 139. Recombinant Human Parathyroid Hormone Market Restraints
Table 140. Recombinant Human Parathyroid Hormone Distributors List
Table 141. Recombinant Human Parathyroid Hormone Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Parathyroid Hormone Product Picture
Figure 2. Global Recombinant Human Parathyroid Hormone Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Recombinant Human Parathyroid Hormone Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Recombinant Human Parathyroid Hormone Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 25 mcg/dose
Figure 6. Global 25 mcg/dose Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 50 mcg/dose
Figure 8. Global 50 mcg/dose Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 75 mcg/dose
Figure 10. Global 75 mcg/dose Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of 100 mcg/dose
Figure 12. Global 100 mcg/dose Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type in 2022 & 2029
Figure 15. North America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2022
Figure 16. North America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2022
Figure 17. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2022
Figure 18. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2022
Figure 21. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Parathyroid Hormone Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Parathyroid Hormone Revenue in 2022
Figure 27. Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Postmenopausal Women with Osteoporosis
Figure 29. Global Postmenopausal Women with Osteoporosis Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Hypocalcemia in Patients with Hypoparathyroidism
Figure 31. Global Hypocalcemia in Patients with Hypoparathyroidism Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application in 2022 & 2029
Figure 34. North America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2022
Figure 35. North America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2022
Figure 36. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2022
Figure 37. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2022
Figure 40. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Recombinant Human Parathyroid Hormone Manufacturing Cost Structure
Figure 45. Recombinant Human Parathyroid Hormone Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed